Cargando…
Autophagic flux determines cell death and survival in response to Apo2L/TRAIL (dulanermin)
BACKGROUND: Macroautophagy is a catabolic process that can mediate cell death or survival. Apo2 ligand (Apo2L)/tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) treatment (TR) is known to induce autophagy. Here we investigated whether SQSTM1/p62 (p62) overexpression, as a marker of aut...
Autores principales: | Singh, Kamini, Sharma, Arishya, Mir, Maria C, Drazba, Judith A, Heston, Warren D, Magi-Galluzzi, Cristina, Hansel, Donna, Rubin, Brian P, Klein, Eric A, Almasan, Alexandru |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3998041/ https://www.ncbi.nlm.nih.gov/pubmed/24655592 http://dx.doi.org/10.1186/1476-4598-13-70 |
Ejemplares similares
-
PARP Inhibition Sensitizes to Low Dose-Rate Radiation TMPRSS2-ERG Fusion Gene-Expressing and PTEN-Deficient Prostate Cancer Cells
por: Chatterjee, Payel, et al.
Publicado: (2013) -
Evaluation of pharmacodynamic biomarkers in a Phase 1a trial of dulanermin (rhApo2L/TRAIL) in patients with advanced tumours
por: Pan, Y, et al.
Publicado: (2011) -
USP14 Regulates DNA Damage Response and Is a Target for Radiosensitization in Non-Small Cell Lung Cancer
por: Sharma, Arishya, et al.
Publicado: (2020) -
Neferine treatment enhances the TRAIL-induced apoptosis of human prostate cancer cells via autophagic flux and the JNK pathway
por: Nazim, Uddin Md, et al.
Publicado: (2020) -
Surgical procedures suppress autophagic flux in the kidney
por: Brown, Carolyn N., et al.
Publicado: (2021)